Target and Pathway |
Top |
Target(s) |
Lysine-specific demethylase 4A (KDM4A) |
Target Info
|
Inhibitor |
[1] |
Lysine-specific histone demethylase 1 (LSD) |
Target Info
|
Inhibitor |
[1] |
Monoamine oxidase type B (MAO-B) |
Target Info
|
Inhibitor |
[1] |
Target's Patent Info |
Lysine-specific demethylase 4A (KDM4A) |
Target's Patent Info
|
[1] |
Lysine-specific histone demethylase 1 (LSD) |
Target's Patent Info
|
[1] |
Monoamine oxidase type B (MAO-B) |
Target's Patent Info
|
[1] |
BioCyc
|
Superpathway of tryptophan utilization
|
Tryptophan degradation via tryptamine
|
Dopamine degradation
|
Putrescine degradation III
|
Noradrenaline and adrenaline degradation
|
KEGG Pathway
|
Glycine, serine and threonine metabolism
|
Arginine and proline metabolism
|
Histidine metabolism
|
Tyrosine metabolism
|
Phenylalanine metabolism
|
Tryptophan metabolism
|
Drug metabolism - cytochrome P450
|
Metabolic pathways
|
Serotonergic synapse
|
Dopaminergic synapse
|
Cocaine addiction
|
Amphetamine addiction
|
Alcoholism
|
Panther Pathway
|
Adrenaline and noradrenaline biosynthesis
|
5-Hydroxytryptamine degredation
|
Dopamine receptor mediated signaling pathway
|
Pathway Interaction Database
|
Notch signaling pathway
|
Coregulation of Androgen receptor activity
|
Notch-mediated HES/HEY network
|
Alpha-synuclein signaling
|
Reactome
|
HDACs deacetylate histones
|
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
|
Factors involved in megakaryocyte development and platelet production
|
WikiPathways
|
Factors involved in megakaryocyte development and platelet production
|
Androgen receptor signaling pathway
|
Tryptophan metabolism
|
Dopamine metabolism
|
Phase 1 - Functionalization of compounds
|